Globus Medical, Inc. revised earnings guidance for the year 2023. The company increased its full-year fiscal 2023 revenue guidance to $1.55 billion, up from $1.125 billion, and reaffirmed non-GAAP fully diluted earnings per share guidance of $2.30.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.41 USD | +0.27% |
|
+0.58% | +26.50% |
06-21 | RBC Raises Price Target on Globus Medical to $76 From $70, Maintains Outperform Rating | MT |
06-18 | Orthofix Medical Inc. Appoints Aviva Mcpherron as President of Global Operations and Quality | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.50% | 9.1B | |
-4.16% | 184B | |
-2.39% | 103B | |
-4.08% | 67.59B | |
+16.04% | 46.93B | |
-11.10% | 43.87B | |
+8.28% | 41.2B | |
+17.63% | 30.47B | |
-8.10% | 23.57B | |
+13.59% | 24.16B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Globus Medical, Inc. Revises Earnings Guidance for the Year 2023